Journal profile · RHEUMATOLOGY
European Journal of Rheumatology
ISSN 2147-9720 · eISSN 2148-4279 · AVES Yayincilik · Turkey
European Journal of Rheumatology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.5 (journal website); fully open access; APC about USD 1,950; review about 7 weeks (community reports); 50 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
European Journal of Rheumatology is published by AVES Yayincilik and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research and Spondyloarthritis Studies and Treatments, together about 33.4% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
Publishes studies contributing to clinical practice in the diagnosis and treatment of rheumatic diseases. A transparent peer review process and a wide international readership support the dissemination of scientific knowledge.
From the journal's Aims & Scope
Research area (LetPub): RHEUMATOLOGY
Editor-in-chief Ioannis Parodis DivisionPublisher website
Editorial board by country: 1 in mainland China (about 8%); most named Türkiye 5, Mainland China 1, United States 1, Japan 1, Italy 1 (12 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Rheumatoid Arthritis Research and TherapiesMedicine14.1%
- Systemic Lupus Erythematosus ResearchMedicine10.2%
- Spondyloarthritis Studies and TreatmentsMedicine9.1%
- Vasculitis and related conditionsMedicine7.7%
- Systemic Sclerosis and Related DiseasesMedicine6.1%
- Ocular Diseases and Behçet’s SyndromeMedicine4.9%
- Autoimmune and Inflammatory Disorders ResearchMedicine4.7%
- Inflammatory Myopathies and DermatomyositisMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.5Publisher website ·
- h-index
- 36OpenAlex ·
- i10-index
- 231OpenAlex ·
- 2-year mean citedness
- 0.85OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 93.81%LetPub ·
Volume
- Articles per year
- 36LetPub ·
Articles by year OpenAlex count · 723 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 17 | 17 | 3 |
| 2025 | 50 | 50 | 39 |
| 2024 | 29 | 29 | 40 |
| 2023 | 37 | 37 | 158 |
| 2022 | 61 | 61 | 397 |
| 2021 | 25 | 25 | 122 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 7 weeksLetPub ·
- Submission to first decision
- 26 daysPublisher website ·
- Submission to publication (journal-reported)
- about 7 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,950 | Yes | CC BY-NC | |
| LetPub | No APC | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- AVES Yayincilik
- Country or region
- Turkey
- Language
- English
- ISSN
- 2147-9720
- Electronic ISSN
- 2148-4279
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about European Journal of Rheumatology
What CAS zone is European Journal of Rheumatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, European Journal of Rheumatology is in Zone 4 of Medicine, and in Zone 4 of the minor category Rheumatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of European Journal of Rheumatology?
The journal's website gives an impact factor of 1.5; this is the journal's own figure, as LetPub lists none for it; h-index 36.
How long does peer review take at European Journal of Rheumatology?
Authors report an average review time of about 7 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of European Journal of Rheumatology based?
Of the 12 board members whose country the journal's board page names, 1 (about 8%) are in mainland China; the countries named most often are Türkiye (5), Mainland China (1) and United States (1). Counted from the institutions listed on the board page; for reference only.
Which databases index European Journal of Rheumatology?
According to LetPub and DOAJ records, European Journal of Rheumatology is indexed in ESCI and DOAJ. The journal's website also lists PubMed; that list has not been checked against each database.
Is European Journal of Rheumatology open access, and what is the APC?
European Journal of Rheumatology is a fully open-access journal. APC about USD 1,950.
Sources and updates
The facts on this page come from LetPub, DOAJ, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .